Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_25151 | 165 | 3.44 | Mlig455_040052 | Neo: - Age: Down-Up-Up Region-enriched R8: 4.085/0.00147 |
Mlig455_040052 {REF} {Length: 2343} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.6]} {Smed: dd_Smed_v6_2982_0_2, dd_Smed_v6_2982_0_2, [Score=94.4, Expect=5e-22]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.75 | 2.025 | 1.00000 | 1.00000 | |
RegionR2 | -0.026 | 2.025 | 0.65729 | 0.99018 | |
RegionR3 | 2.378 | 2.025 | 0.00477 | 0.09204 | |
RegionR4 | -0.196 | 2.025 | 0.75125 | 1.00000 | |
RegionR5 | -0.569 | 2.025 | 0.81454 | 1.00000 | |
RegionR6 | -4.932 | 2.025 | 1.00000 | 1.00000 | |
RegionR7 | 3.011 | 2.025 | 0.00145 | 0.04533 | |
RegionR8 | 4.085 | 2.025 | 0.00001 | 0.00147 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.383 | 2.025 | 0.99999 | 1.00000 | |
RegenerationR2 | 0.087 | 2.025 | 0.93346 | 1.00000 | |
RegenerationR3 | -0.845 | 2.025 | 0.38136 | 0.79132 | |
RegenerationR4 | -1.045 | 2.025 | 0.44823 | 0.84083 | |
RegenerationR5 | -0.242 | 2.025 | 0.84570 | 1.00000 | |
RegenerationR6 | 2.13 | 2.025 | 0.23793 | 0.58538 | |
RegenerationBL | -0.736 | 2.025 | 0.77493 | 1.00000 | |
RegenerationTP | -1.5 | 2.025 | 0.13870 | 0.55644 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_25151 | 165 | 3.44 | Mlig455_040052 | Neo: - Age: Down-Up-Up Region-enriched R8: 4.085/0.00147 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_040052 {REF} {Length: 2343} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.6]} {Smed: dd_Smed_v6_2982_0_2, dd_Smed_v6_2982_0_2, [Score=94.4, Expect=5e-22]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
2. | MligTC455_25152 | 168 | 3.51 | Mlig455_040072 | Neo: - Age: - Region-enriched R8: 4.101/0.00210 |
5.866 | 0.998 | 1.000 | 0.999 | 0.943 | 0.993 | 0.933 | Mlig455_040072 {REF} {Length: 2067} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=43.4]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.9]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=57.8, Expect=1e-09]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
3. | MligTC455_38826 | 244 | 5.08 | Mlig455_059316 | Neo: - Age: Up-Down-Up Region-enriched R8: 3.511/0.00478 |
RDX | 2.812 | 0.954 | - | - | 0.910 | - | 0.948 | Mlig455_059316 {REF} {Length: 3395} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
4. | MligTC455_38827 | 168 | 3.49 | Mlig455_065185 | Neo: - Age: - Region-enriched R8: 3.346/0.01415 |
RDX | 2.772 | 0.957 | - | - | 0.909 | - | 0.906 | Mlig455_065185 {REF} {Length: 3409} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
5. | MligTC455_39978 | 270 | 5.62 | Mlig455_052261, Mlig455_052349 | Neo: - Age: Down-Up-Up Region-enriched R8: 3.650/0.00368 |
2.752 | 0.976 | - | - | 0.839 | - | 0.937 | Mlig455_052261 {REF} {Length: 760} {RNA1310_41850} {RNA815_20313} Mlig455_052349 {REF} {Length: 710} {RNA1310_41850} {RNA815_20313} |
|
6. | MligTC455_19110 | 45 | 0.93 | Mlig455_068563 | Neo: - |
2.668 | - | - | 0.973 | 0.889 | - | 0.806 | Mlig455_068563 {REF} {Length: 2503} {RNA1310_41313} {RNA815_22204} | |
7. | MligTC455_06772 | 238 | 4.96 | Mlig455_048772 | Neo: - Age: - Region-enriched R8: 6.268/0.00000 |
2.623 | 0.952 | - | - | 0.842 | - | 0.829 | Mlig455_048772 {REF} {Length: 839} {RNA1310_24767.2} {RNA815_33473} | |
8. | MligTC455_06773 | 251 | 5.23 | Mlig455_069732 | Neo: - Age: Down-Up-Down |
2.61 | 0.952 | - | - | 0.842 | - | 0.816 | Mlig455_069732 {REF} {Length: 1347} {RNA1310_24767.1} {RNA815_33473} | |
9. | MligTC455_52902 | 41 | 0.84 | Mlig455_053281 | Neo: - Age: - |
TRPC6 | 2.544 | 0.812 | - | - | - | 0.765 | 0.967 | Mlig455_053281 {REF} {Length: 3581} {Pfam: Ion transport protein [PF00520.33, score=32.2]} {Human: ENSG00000137672, TRPC6, transient receptor potential cation channel subfamily C member 6, [Score=124, Expect=2e-28]} {Mouse: ENSMUSG00000031997, Trpc6, transient receptor potential cation channel, subfamily C, member 6, [Score=115, Expect=4e-26]; ENSMUSG00000021541, Trpc7, transient receptor potential cation channel, subfamily C, member 7, [Score=112, Expect=4e-25]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=111, Expect=9e-25]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=66.6, Expect=5e-11]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [Score=85.9, Expect=4e-17]} {RNA1509_36039} {RNA1310_4382} {RNA815_15390} |
10. | MligTC455_31059 | 571 | 11.9 | Mlig455_013389 | Neo: - Age: - Region-enriched R7: 2.543/0.00000 Regeneration-downregulated BL: -2.866 Regeneration-depleted BL: -2.866 |
2.534 | - | - | - | 0.861 | 0.720 | 0.953 | Mlig455_013389 {REF} {Length: 3375} {Pfam: Profilin [PF00235.21, score=45.7]} {Smed: dd_Smed_v6_6034_0_1, dd_Smed_v6_6034_0_1, [RH, Score=79.3, Expect=5e-17]} {RNA1509_42370} {RNA1310_22792.1} {RNA815_5445} | |
11. | MligTC455_37537 | 203 | 4.23 | Mlig455_047747 | Neo: - Age: - Region-enriched R8: 3.525/0.01192 |
KCNC2 | 2.476 | 0.971 | - | - | - | 0.805 | 0.700 | Mlig455_047747 {REF} {Length: 3532} {Pfam: Ion transport protein [PF00520.33, score=105.8]; BTB/POZ domain [PF02214.24, score=56.8]; Ion channel [PF07885.18, score=52.6]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=216, Expect=4e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=215, Expect=5e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=207, Expect=1e-56]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=1e-65]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=211, Expect=5e-59]} {Smed: dd_Smed_v6_9740_0_2, dd_Smed_v6_9740_0_2, [Score=208, Expect=6e-58]} {RNA1509_26535} {RNA1310_14101} {RNA815_34993} |
12. | MligTC455_19211 | 107 | 2.23 | Mlig455_052588 | Neo: - Age: - Region-enriched R8: 3.795/0.01587 |
1.858 | 0.973 | - | - | - | - | 0.885 | Mlig455_052588 {REF} {Length: 2340} {Celegans: WBGene00019180, H10D18.5, [RH, Score=62.4, Expect=6e-11]} {Smed: dd_Smed_v6_10251_0_1, dd_Smed_v6_10251_0_1, [RH, Score=95.9, Expect=2e-23]} {RNA1509_8096} {RNA1310_25906} {RNA815_14581.1} | |
13. | MligTC455_15087 | 28 | 0.59 | Mlig455_036738 | Neo: - Age: - |
1.83 | - | - | - | 0.867 | 0.963 | - | Mlig455_036738 {REF} {Length: 821} {RNA1509_18025} {RNA1310_92583} {RNA815_44681} | |
14. | MligTC455_33356 | 149 | 3.11 | Mlig455_025778 | Neo: - Age: - |
SP4 | 1.812 | 0.969 | - | - | - | - | 0.843 | Mlig455_025778 {REF} {Length: 2800} {Pfam: Zinc-finger double domain [PF13465.8, score=45.8]; Zinc finger, C2H2 type [PF00096.28, score=44.8]; C2H2-type zinc finger [PF13894.8, score=29.7]} {Human: ENSG00000105866, SP4, Sp4 transcription factor, [RH, Score=186, Expect=2e-52]; ENSG00000185591, SP1, Sp1 transcription factor, [RH, Score=180, Expect=5e-50]} {Mouse: ENSMUSG00000025323, Sp4, trans-acting transcription factor 4, [RH, Score=190, Expect=6e-54]} {Dmel: FBgn0039169, Spps, Sp1-like factor for pairing sensitive-silencing, [RH, Score=174, Expect=4e-48]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [RH, Score=155, Expect=1e-43]} {Smed: dd_Smed_v6_7824_0_1, dd_Smed_v6_7824_0_1, [RH, Score=171, Expect=1e-49]} {RNA1509_53494} {RNA1310_27619} {RNA815_23917} |
15. | MligTC455_11069 | 184 | 3.83 | Mlig455_038504 | Neo: - Age: - |
1.795 | 0.964 | - | - | 0.831 | - | - | Mlig455_038504 {REF} {Length: 816} {RNA1310_51357} {RNA815_24712} | |
16. | MligTC455_35188 | 340 | 7.08 | Mlig455_017705, Mlig455_017757 | Neo: - Age: - Region-enriched R7: 4.175/0.00000 |
PLEKHB1 | 1.776 | - | - | - | 0.815 | - | 0.961 | Mlig455_017705 {REF} {Length: 1121} {Pfam: PH domain [PF00169.31, score=38.5]} {Human: ENSG00000021300, PLEKHB1, pleckstrin homology domain containing B1, [RH, Score=76.6, Expect=1e-16]; ENSG00000115762, PLEKHB2, pleckstrin homology domain containing B2, [RH, Score=75.5, Expect=3e-16]} {Mouse: ENSMUSG00000030701, Plekhb1, pleckstrin homology domain containing, family B (evectins) member 1, [RH, Score=79.7, Expect=5e-18]; ENSMUSG00000026123, Plekhb2, pleckstrin homology domain containing, family B (evectins) member 2, [RH, Score=78.2, Expect=2e-17]} {Smed: dd_Smed_v6_1927_0_1, dd_Smed_v6_1927_0_1, [RH, Score=124, Expect=4e-35]} {RNA1509_56045} {RNA1310_40666.2} {RNA815_39297} Mlig455_017757 {REF} {Length: 1030} {Pfam: PH domain [PF00169.31, score=38.5]} {Human: ENSG00000021300, PLEKHB1, pleckstrin homology domain containing B1, [RH, Score=76.6, Expect=1e-16]; ENSG00000115762, PLEKHB2, pleckstrin homology domain containing B2, [RH, Score=75.5, Expect=3e-16]} {Mouse: ENSMUSG00000030701, Plekhb1, pleckstrin homology domain containing, family B (evectins) member 1, [RH, Score=79.7, Expect=5e-18]; ENSMUSG00000026123, Plekhb2, pleckstrin homology domain containing, family B (evectins) member 2, [RH, Score=78.2, Expect=2e-17]} {Smed: dd_Smed_v6_1927_0_1, dd_Smed_v6_1927_0_1, [RH, Score=124, Expect=4e-35]} {RNA1509_56045} {RNA1310_40666.2, RNA1509_56045} {RNA1509_56045, RNA815_39297} |
17. | MligTC455_31764 | 62 | 1.28 | Mlig455_006258 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.078/0.01607 |
LMNA | 1.745 | 0.970 | - | 0.775 | - | - | - | Mlig455_006258 {REF} {Length: 2636} {Pfam: Intermediate filament protein [PF00038.23, score=111.4]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=87.8, Expect=7e-18]; ENSG00000026025, VIM, vimentin, [Score=84.7, Expect=4e-17]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=86.3, Expect=2e-17]; ENSMUSG00000026728, Vim, vimentin, [Score=85.5, Expect=2e-17]; ENSMUSG00000095241, Gm5478, predicted pseudogene 5478, [Score=82.8, Expect=2e-16]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=93.6, Expect=5e-20]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=165, Expect=1e-44]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=190, Expect=6e-54]} {RNA1509_56508} {RNA1310_5840} {RNA815_9167} |
18. | MligTC455_30850 | 34 | 0.71 | Mlig455_019341, Mlig455_019556 | Neo: - Age: logFC(26M/2M)=-0.625 |
GRIK2, GRIK4 | 1.723 | 0.955 | - | - | - | - | 0.768 | Mlig455_019341 {REF} {Length: 3886} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.6]; Receptor family ligand binding region [PF01094.30, score=53.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=160, Expect=8e-40]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=6e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=152, Expect=3e-37]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=160, Expect=4e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=153, Expect=6e-38]} {Dmel: FBgn0039927, CG11155, [Score=179, Expect=3e-46]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=257, Expect=5e-78]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019556 {REF} {Length: 4135} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.5]; Receptor family ligand binding region [PF01094.30, score=39.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=19.4]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=155, Expect=3e-38]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=8e-37]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=154, Expect=5e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=149, Expect=1e-36]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=149, Expect=1e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=147, Expect=4e-36]} {Dmel: FBgn0039927, CG11155, [Score=169, Expect=3e-43]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=259, Expect=1e-78]} {RNA1509_10728} {RNA1310_31364} {RNA815_8415.1} |
19. | MligTC455_19388 | 162 | 3.37 | Mlig455_002030, Mlig455_002121 | Neo: - Age: logFC(26M/2M)=-0.394 |
1.715 | - | - | - | - | 0.761 | 0.954 | Mlig455_002030 {REF} {Length: 1765} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.9]} {Smed: dd_Smed_v6_7982_0_2, dd_Smed_v6_7982_0_2, [Score=101, Expect=9e-25]} {RNA1509_55345} {RNA1310_23802} {RNA815_37548} Mlig455_002121 {REF} {Length: 2422} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.1]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=101, Expect=3e-24]} {RNA1509_55345} {RNA1310_23802, RNA1509_55345} {RNA1509_55345, RNA815_37548} |
|
20. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 1.712 | 0.954 | - | - | - | - | 0.758 | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
21. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 1.694 | 0.964 | - | - | - | - | 0.730 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
22. | MligTC455_54070 | 186 | 3.88 | Mlig455_067817 | Neo: - Age: - Region-enriched R8: 3.779/0.00038 |
OTOF | 1.665 | 0.950 | - | - | - | 0.715 | - | Mlig455_067817 {REF} {Length: 8297} {Pfam: C2 domain [PF00168.32, score=144.2]; FerB (NUC096) domain [PF08150.14, score=94.3]; FerI (NUC094) domain [PF08151.14, score=59.3]} {Human: ENSG00000115155, OTOF, otoferlin, [Score=829, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [Score=834, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [Score=114, Expect=3e-25]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=84.3, Expect=6e-16]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1263, Expect=0.0]} {RNA1509_37008} {RNA1310_908.1} {RNA815_16140} |
23. | MligTC455_17916 | 136 | 2.84 | Mlig455_049602 | Neo: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_049602 {REF} {Length: 643} {RNA1310_87578} {RNA815_52625} | |
24. | MligTC455_35333 | 90 | 1.87 | Mlig455_067763 | Neo: - Age: - |
RPS6KB1 | 0.984 | 0.984 | - | - | - | - | - | Mlig455_067763 {REF} {Length: 2200} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.1]; Protein kinase C terminal domain [PF00433.26, score=39.1]; Kinase-like [PF14531.8, score=30.7]} {Human: ENSG00000108443, RPS6KB1, ribosomal protein S6 kinase B1, [Score=453, Expect=2e-155]; ENSG00000175634, RPS6KB2, ribosomal protein S6 kinase B2, [Score=441, Expect=2e-150]} {Mouse: ENSMUSG00000020516, Rps6kb1, ribosomal protein S6 kinase, polypeptide 1, [Score=452, Expect=2e-154]; ENSMUSG00000097721, Rps6kb2, ribosomal protein S6 kinase, polypeptide 2, [Score=431, Expect=1e-146]; ENSMUSG00000024830, Rps6kb2, ribosomal protein S6 kinase, polypeptide 2, [Score=431, Expect=1e-146]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=437, Expect=5e-149]} {Celegans: WBGene00012929, rsks-1, Ribosomal protein S6 kinase beta, [Score=427, Expect=2e-144]} {Smed: dd_Smed_v6_5658_0_1, dd_Smed_v6_5658_0_1, [RH, Score=466, Expect=2e-160]} {RNA1509_36368} {RNA1310_14771.1} {RNA815_3550} |
25. | MligTC455_46622 | 41 | 0.86 | Mlig455_019865 | Neo: - Age: Down-Up-Up Region-enriched R4: 3.981/0.04149 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_019865 {REF} {Length: 2038} {RNA1310_27198} {RNA815_14877} | |
26. | MligTC455_16622 | 10 | 0.21 | Mlig455_057188 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_057188 {REF} {Length: 2124} {RNA1310_87812} | |
27. | MligTC455_21498 | 17 | 0.36 | Mlig455_020602 | Neo: - Age: - |
GRIK2 | 0.982 | - | - | - | - | 0.982 | - | Mlig455_020602 {REF} {Length: 2918} {Pfam: Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=41.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=36.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=65.1, Expect=2e-10]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=63.5, Expect=5e-10]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=65.5, Expect=9e-11]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=63.5, Expect=3e-10]} {Dmel: FBgn0004620, GluRIIA, Glutamate receptor IIA, [Score=54.7, Expect=1e-07]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=51.2, Expect=1e-06]} {Smed: dd_Smed_v6_20242_0_1, dd_Smed_v6_20242_0_1, [Score=51.2, Expect=1e-06]} {RNA1310_56126} {RNA815_40955} |
28. | MligTC455_19712 | 82 | 1.7 | Mlig455_000384 | Neo: - Age: - |
0.981 | - | - | - | - | - | 0.981 | Mlig455_000384 {REF} {Length: 1367} {NoTransDecoderORF} {RNA1310_88029.2} {RNA815_48482} | |
29. | MligTC455_24081 | 60 | 1.25 | Mlig455_032844 | Neo: - |
MUC4 | 0.981 | - | - | - | - | - | 0.981 | Mlig455_032844 {REF} {Length: 2899} {Pfam: von Willebrand factor type D domain [PF00094.27, score=29.2]} {Human: ENSG00000277585, MUC4, mucin 4, cell surface associated, [Score=99.0, Expect=5e-21]; ENSG00000278468, MUC4, mucin 4, cell surface associated, [Score=99.0, Expect=5e-21]; ENSG00000278303, MUC4, mucin 4, cell surface associated, [Score=98.6, Expect=7e-21]; ENSG00000145113, MUC4, mucin 4, cell surface associated, [Score=98.6, Expect=7e-21]; ENSG00000276613, MUC4, mucin 4, cell surface associated, [Score=98.6, Expect=7e-21]; ENSG00000273984, MUC4, mucin 4, cell surface associated, [Score=98.6, Expect=7e-21]; ENSG00000273822, MUC4, mucin 4, cell surface associated, [Score=98.6, Expect=7e-21]} {Mouse: ENSMUSG00000079620, Muc4, mucin 4, [Score=89.7, Expect=3e-18]} {Dmel: FBgn0051004, mesh, [Score=48.9, Expect=1e-05]} {RNA1509_26110} {RNA1310_679.1} {RNA815_472.1} |
30. | MligTC455_26248 | 162 | 3.38 | Mlig455_052600, Mlig455_052650 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_052600 {REF} {Length: 3376} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} Mlig455_052650 {REF} {Length: 3364} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} |
|
31. | MligTC455_02588 | 124 | 2.59 | Mlig455_027269 | Neo: - Age: - Region-enriched R8: 3.886/0.02772 |
MX2 | 0.973 | 0.973 | - | - | - | - | - | Mlig455_027269 {REF} {Length: 3110} {Pfam: Dynamin central region [PF01031.22, score=151.0]; Dynamin family [PF00350.25, score=125.4]; Dynamin GTPase effector domain [PF02212.20, score=54.8]; 50S ribosome-binding GTPase [PF01926.25, score=24.2]; AAA ATPase domain [PF13175.8, score=21.4]; Family with sequence similarity 184, A and B [PF15665.7, score=18.9]} {Human: ENSG00000183486, MX2, MX dynamin like GTPase 2, [RH, Score=347, Expect=1e-108]; ENSG00000157601, MX1, MX dynamin like GTPase 1, [RH, Score=334, Expect=1e-104]} {Mouse: ENSMUSG00000023341, Mx2, MX dynamin-like GTPase 2, [RH, Score=343, Expect=3e-108]} {Dmel: FBgn0003392, shi, shibire, [Score=153, Expect=2e-38]} {Celegans: WBGene00001130, dyn-1, Dynamin, [Score=164, Expect=4e-42]} {Smed: dd_Smed_v6_1818_0_1, dd_Smed_v6_1818_0_1, [Score=165, Expect=4e-43]} {RNA1509_19894} {RNA1310_7243} {RNA815_3194} |
32. | MligTC455_19025 | 86 | 1.79 | Mlig455_037631 | Neo: Int S/G2/M Age: Up-Down-Down |
0.973 | - | - | - | - | 0.973 | - | Mlig455_037631 {REF} {Length: 2219} {RNA1509_32306} {RNA1310_31823.1} {RNA815_14423} | |
33. | MligTC455_15564 | 86 | 1.79 | Mlig455_054618 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_054618 {REF} {Length: 920} {NoTransDecoderORF} {RNA1310_55174} {RNA815_12298} | |
34. | MligTC455_14583 | 33 | 0.69 | Mlig455_008303, Mlig455_008334 | Neo: - Age: - |
ADAM33, ADAM9 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_008303 {REF} {Length: 2620} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=143.0]; Metallo-peptidase family M12 [PF13688.8, score=76.4]; Disintegrin [PF00200.25, score=72.2]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=45.7]; ADAM cysteine-rich [PF08516.14, score=45.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=41.2]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=37.2]} {Human: ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=249, Expect=1e-71]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=242, Expect=7e-68]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [Score=258, Expect=4e-74]} {Dmel: FBgn0265140, Meltrin, [Score=273, Expect=1e-78]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=233, Expect=6e-65]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=201, Expect=1e-53]} {RNA1509_45880} {RNA1310_77182} {RNA815_37786} Mlig455_008334 {REF} {Length: 2763} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=125.2]; Disintegrin [PF00200.25, score=72.6]; Metallo-peptidase family M12 [PF13688.8, score=64.4]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=46.3]; ADAM cysteine-rich [PF08516.14, score=44.9]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=40.6]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=32.8]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=224, Expect=4e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=221, Expect=1e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=219, Expect=7e-61]; ENSG00000134007, ADAM20, ADAM metallopeptidase domain 20, [Score=216, Expect=2e-60]; ENSG00000143537, ADAM15, ADAM metallopeptidase domain 15, [Score=215, Expect=5e-60]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [Score=229, Expect=6e-65]; ENSMUSG00000054555, Adam12, a disintegrin and metallopeptidase domain 12 (meltrin alpha), [Score=221, Expect=5e-62]; ENSMUSG00000025473, Adam8, a disintegrin and metallopeptidase domain 8, [Score=219, Expect=6e-62]} {Dmel: FBgn0265140, Meltrin, [Score=247, Expect=7e-71]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=218, Expect=7e-61]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=194, Expect=2e-52]} {RNA1509_45880} {RNA1310_77182} {RNA815_1440.1} |
35. | MligTC455_24150 | 13 | 0.28 | Mlig455_035590, Mlig455_051881 | Neo: - Age: - |
ISL1 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_035590 {REF} {Length: 2901} {Pfam: LIM domain [PF00412.24, score=70.1]; Homeodomain [PF00046.31, score=55.4]; Homeobox KN domain [PF05920.13, score=23.5]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=265, Expect=2e-84]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=255, Expect=3e-80]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=265, Expect=1e-84]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=253, Expect=1e-79]} {Dmel: FBgn0003896, tup, tailup, [Score=156, Expect=4e-42]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=187, Expect=6e-54]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=232, Expect=4e-70]} {RNA1310_96806.2} {RNA815_55988} Mlig455_051881 {REF} {Length: 2804} {Pfam: LIM domain [PF00412.24, score=93.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.5]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [RH, Score=303, Expect=6e-99]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [RH, Score=293, Expect=5e-95]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [RH, Score=303, Expect=4e-99]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [RH, Score=291, Expect=2e-94]} {Dmel: FBgn0003896, tup, tailup, [RH, Score=171, Expect=5e-47]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=221, Expect=2e-66]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=271, Expect=6e-85]} {RNA1310_96806.2} {RNA815_55988} |
36. | MligTC455_46047 | 71 | 1.48 | Mlig455_003968, Mlig455_012751, Mlig455_019818, Mlig455_042549 | Neo: - Age: Up-Down-Down |
0.971 | - | - | - | - | - | 0.971 | Mlig455_003968 {REF} {Length: 1636} {RNA1509_32911} {RNA1310_1680} {RNA815_2080} Mlig455_012751 {REF} {Length: 1531} {RNA1509_15268} {RNA1310_1680} {RNA815_2080} Mlig455_019818 {REF} {Length: 1294} {NoTransDecoderORF} {RNA1509_15268} {RNA1310_1680} {RNA815_2080} Mlig455_042549 {REF} {Length: 1623} {RNA1509_32911} {RNA1310_1680} {RNA815_2080} |
|
37. | MligTC455_51176 | 71 | 1.48 | Mlig455_024765 | Neo: - Age: - |
SAXO1 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_024765 {REF} {Length: 1803} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_5551_0_1, dd_Smed_v6_5551_0_1, [Score=55.5, Expect=2e-08]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
38. | MligTC455_11660 | 8 | 0.17 | Mlig455_064306 | Neo: - Age: Up-Down-Down |
0.969 | - | - | - | - | 0.969 | - | Mlig455_064306 {REF} {Length: 789} {Pfam: Integrase core domain [PF00665.28, score=46.4]; Integrase zinc binding domain [PF17921.3, score=28.1]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=132, Expect=1e-35]} {RNA1509_2485} {RNA1310_391} {RNA815_131.1} | |
39. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 0.966 | 0.966 | - | - | - | - | - | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
40. | MligTC455_35161 | 35 | 0.73 | Mlig455_012119 | Neo: - Age: Down-Up-Down |
0.965 | - | - | - | - | - | 0.965 | Mlig455_012119 {REF} {Length: 3213} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]} {Smed: dd_Smed_v6_13661_0_1, dd_Smed_v6_13661_0_1, [Score=81.3, Expect=2e-17]} {RNA1509_53704} {RNA1310_36988} {RNA815_11369} | |
41. | MligTC455_16675 | 34 | 0.72 | Mlig455_056031 | Neo: Int S/G2/M Age: Up-Down-Down |
PAX3 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_056031 {REF} {Length: 3186} {Pfam: 'Paired box' domain [PF00292.20, score=173.3]; Homeodomain [PF00046.31, score=75.8]; Homeodomain-like domain [PF13384.8, score=22.9]; Homeodomain-like domain [PF13565.8, score=21.7]; Winged helix-turn helix [PF13551.8, score=20.5]; Homeobox KN domain [PF05920.13, score=20.4]} {Human: ENSG00000135903, PAX3, paired box 3, [Score=224, Expect=5e-67]} {Mouse: ENSMUSG00000028736, Pax7, paired box 7, [Score=224, Expect=9e-67]; ENSMUSG00000004872, Pax3, paired box 3, [Score=221, Expect=5e-66]} {Dmel: FBgn0003145, prd, paired, [Score=226, Expect=8e-67]} {Celegans: WBGene00006870, vab-3, MAB-18, [Score=186, Expect=4e-53]} {Smed: dd_Smed_v6_17726_0_1, dd_Smed_v6_17726_0_1, [Score=187, Expect=5e-53]} {RNA1310_110100} {RNA815_50358} |
42. | MligTC455_38993 | 26417 | 550.35 | Mlig455_033850, Mlig455_033866 | Neo: - Age: - Region-enriched R7: 2.780/0.00000 Regeneration-downregulated BL: -2.507 Regeneration-depleted BL: -2.507 |
0.964 | - | - | - | - | - | 0.964 | Mlig455_033850 {REF} {Length: 1214} {RNA1509_35790, RNA1509_4103} {RNA1310_83034, RNA1509_4103} {RNA1509_4103, RNA815_21458.1} Mlig455_033866 {REF} {Length: 1213} {RNA1509_17959, RNA1509_25065, RNA1509_35790, RNA1509_56573} {RNA1310_83034, RNA1509_17959, RNA1509_25065, RNA1509_56573} {RNA1509_17959, RNA1509_25065, RNA1509_56573, RNA815_21458.1} |
|
43. | MligTC455_48843 | 660 | 13.74 | Mlig455_044615 | Neo: - Age: - |
0.963 | - | - | - | 0.963 | - | - | Mlig455_044615 {REF} {Length: 2002} {TRANSSPLICED} {RNA1509_29862} {RNA1310_13775, RNA1509_29862} {RNA1509_29862, RNA815_10034} | |
44. | MligTC455_37711 | 41 | 0.86 | Mlig455_009915 | Neo: - Age: - |
0.961 | 0.961 | - | - | - | - | - | Mlig455_009915 {REF} {Length: 1326} {RNA1509_26004} {RNA1310_89855.1} {RNA815_1664.2} | |
45. | MligTC455_42157 | 340 | 7.09 | Mlig455_025121 | Neo: - Age: - |
0.959 | 0.959 | - | - | - | - | - | Mlig455_025121 {REF} {Length: 5069} {Smed: dd_Smed_v6_4268_0_1, dd_Smed_v6_4268_0_1, [RH, Score=76.6, Expect=7e-16]} {RNA1509_57041, RNA1509_57438} {RNA1310_30507, RNA1509_57041} {RNA1509_57041, RNA815_19089} | |
46. | MligTC455_05978 | 20 | 0.42 | Mlig455_000159, Mlig455_000172 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_000159 {REF} {Length: 914} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} Mlig455_000172 {REF} {Length: 910} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} |
|
47. | MligTC455_13851 | 234 | 4.88 | Mlig455_022549, Mlig455_025480 | Neo: - Age: Down-Up-Up Region-enriched R8: 3.637/0.03982 |
FBXO8 | 0.958 | 0.958 | - | - | - | - | - | Mlig455_022549 {REF} {Length: 2557} {TRANSSPLICED} {Pfam: Sec7 domain [PF01369.22, score=87.5]; F-box-like [PF12937.9, score=25.7]; F-box domain [PF00646.35, score=21.4]} {Human: ENSG00000164117, FBXO8, F-box protein 8, [Score=263, Expect=4e-85]} {Mouse: ENSMUSG00000038206, Fbxo8, F-box protein 8, [Score=264, Expect=8e-86]} {Dmel: FBgn0051158, Efa6, Exchange factor for Arf 6, [Score=59.3, Expect=4e-09]} {Smed: dd_Smed_v6_11857_0_2, dd_Smed_v6_11857_0_2, [Score=278, Expect=4e-92]} {RNA1509_27536} {RNA1310_35513} {RNA815_17059} Mlig455_025480 {REF} {Length: 2554} {TRANSSPLICED} {Pfam: Sec7 domain [PF01369.22, score=87.5]; F-box-like [PF12937.9, score=25.7]; F-box domain [PF00646.35, score=21.4]} {Human: ENSG00000164117, FBXO8, F-box protein 8, [Score=263, Expect=4e-85]} {Mouse: ENSMUSG00000038206, Fbxo8, F-box protein 8, [Score=264, Expect=8e-86]} {Dmel: FBgn0051158, Efa6, Exchange factor for Arf 6, [Score=59.3, Expect=4e-09]} {Smed: dd_Smed_v6_11857_0_2, dd_Smed_v6_11857_0_2, [Score=278, Expect=4e-92]} {RNA1509_27536} {RNA1310_35513} {RNA815_17059} |
48. | MligTC455_03019 | 65 | 1.35 | Mlig455_030634 | Neo: - Age: Up-Down-Down |
PCDH7 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_030634 {REF} {Length: 1514} {Pfam: Cadherin domain [PF00028.19, score=251.4]} {Human: ENSG00000169851, PCDH7, protocadherin 7, [Score=236, Expect=2e-63]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=263, Expect=2e-72]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=1e-53]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=172, Expect=3e-43]} {Smed: dd_Smed_v6_17019_0_1, dd_Smed_v6_17019_0_1, [Score=290, Expect=8e-83]} {RNA1509_5672} {RNA1310_54671.1} {RNA815_2173} |
49. | MligTC455_17975 | 19 | 0.4 | Mlig455_001959 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_001959 {REF} {Length: 699} {RNA1310_56725} {RNA815_29666} | |
50. | MligTC455_23598 | 236 | 4.92 | Mlig455_025573 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.347/0.00904 Regeneration-downregulated BL: -7.152 Regeneration-depleted BL: -7.152 |
FBN1 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_025573 {REF} {Length: 8300} {Pfam: Calcium-binding EGF domain [PF07645.17, score=308.8]; Complement Clr-like EGF-like [PF12662.9, score=240.6]; Coagulation Factor Xa inhibitory site [PF14670.8, score=137.8]; EGF domain [PF12947.9, score=103.1]; EGF-like domain [PF00008.29, score=67.3]; Human growth factor-like EGF [PF12661.9, score=42.0]; Thrombospondin type 1 domain [PF00090.21, score=27.9]; MSP1 EGF domain 1 [PF12946.9, score=23.5]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=274, Expect=5e-73]; ENSG00000138829, FBN2, fibrillin 2, [Score=265, Expect=2e-70]; ENSG00000142449, FBN3, fibrillin 3, [Score=263, Expect=1e-69]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=291, Expect=2e-78]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=235, Expect=8e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=165, Expect=2e-41]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=292, Expect=8e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
51. | MligTC455_28563 | 196 | 4.09 | Mlig455_061802 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.606/0.00003 |
KCNJ12 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_061802 {REF} {Length: 5059} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=168.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=315, Expect=3e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=8e-103]; ENSG00000123700, KCNJ2, potassium voltage-gated channel subfamily J member 2, [Score=300, Expect=1e-98]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=316, Expect=6e-105]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=6e-99]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=311, Expect=9e-102]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=296, Expect=4e-97]} {RNA1509_57087} {RNA1310_22528, RNA1509_57087} {RNA1509_57087, RNA815_8424.1} |
52. | MligTC455_28564 | 383 | 7.97 | Mlig455_010532, Mlig455_061843 | Neo: - Age: - Region-enriched R8: 4.824/0.00000 |
KCNJ12 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_010532 {REF} {Length: 1728} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=178.4]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=147.1]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=260, Expect=1e-83]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=256, Expect=4e-82]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=261, Expect=3e-84]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=251, Expect=7e-80]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=256, Expect=2e-81]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=246, Expect=5e-78]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} Mlig455_061843 {REF} {Length: 1636} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=167.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=314, Expect=6e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=315, Expect=1e-104]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=1e-98]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=310, Expect=2e-101]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=297, Expect=3e-97]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} |
53. | MligTC455_47731 | 19 | 0.4 | Mlig455_061021 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_061021 {REF} {Length: 1271} {NoTransDecoderORF} {RNA1509_46050} {RNA1310_22065.1} | |
54. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 0.954 | - | - | - | - | 0.954 | - | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
55. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
56. | MligTC455_45008 | 629 | 13.1 | Mlig455_016672 | Neo: - Age: logFC(26M/2M)=-0.566 Region-enriched R7: 2.290/0.00017 |
0.954 | - | - | - | 0.954 | - | - | Mlig455_016672 {REF} {Length: 1196} {RNA1509_41773} {RNA1310_50243, RNA1509_41773} {RNA1509_41773, RNA815_30201} | |
57. | MligTC455_24661 | 112 | 2.33 | Mlig455_019924 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.668/0.00712 |
URGCP | 0.953 | 0.953 | - | - | - | - | - | Mlig455_019924 {REF} {Length: 10713} {TRANSSPLICED} {Pfam: Dynamin family [PF00350.25, score=30.5]; Guanylate-binding protein, N-terminal domain [PF02263.21, score=23.0]; 50S ribosome-binding GTPase [PF01926.25, score=21.4]} {Human: ENSG00000106608, URGCP, upregulator of cell proliferation, [Score=171, Expect=3e-42]} {Mouse: ENSMUSG00000045868, Gvin1, GTPase, very large interferon inducible 1, [Score=397, Expect=5e-111]; ENSMUSG00000078606, Gm4070, predicted gene 4070, [Score=397, Expect=5e-111]} {RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932} {RNA1310_285, RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932} {RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932, RNA815_97.1} |
58. | MligTC455_32067 | 139 | 2.89 | Mlig455_015473, Mlig455_017537, Mlig455_017569, Mlig455_026827, Mlig455_030869 | Neo: - Age: Up-Down-Up Region-enriched R7: 3.552/0.00309 |
GRID2IP, PRR9 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_015473 {REF} {Length: 651} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=45.8, Expect=3e-06]} {Celegans: WBGene00018026, F35A5.4, [Score=65.1, Expect=3e-12]} Mlig455_017537 {REF} {Length: 5509} {Pfam: Formin Homology 2 Domain [PF02181.25, score=277.7]; PDZ domain [PF00595.26, score=97.5]; PDZ domain [PF17820.3, score=91.6]; PDZ domain [PF13180.8, score=66.3]; Cerebral cavernous malformation protein, harmonin-homology [PF16545.7, score=22.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=21.5]} {Human: ENSG00000215045, GRID2IP, Grid2 interacting protein, [RH, Score=244, Expect=6e-66]} {Mouse: ENSMUSG00000010825, Grid2ip, glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1, [RH, Score=240, Expect=2e-64]} {Dmel: FBgn0025641, DAAM, Dishevelled Associated Activator of Morphogenesis, [RH, Score=167, Expect=2e-41]} {Celegans: WBGene00018976, daam-1, DAAM (Disheveled-Associated Activator of Morphogenesis) homolog, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_2533_0_1, dd_Smed_v6_2533_0_1, [RH, Score=138, Expect=8e-33]} {RNA1509_53930} {RNA1310_5747} {RNA815_10432} Mlig455_017569 {REF} {Length: 5516} {Pfam: Formin Homology 2 Domain [PF02181.25, score=277.7]; PDZ domain [PF00595.26, score=100.6]; PDZ domain [PF17820.3, score=94.4]; PDZ domain [PF13180.8, score=69.9]; Cerebral cavernous malformation protein, harmonin-homology [PF16545.7, score=22.4]} {Human: ENSG00000215045, GRID2IP, Grid2 interacting protein, [RH, Score=245, Expect=5e-66]} {Mouse: ENSMUSG00000010825, Grid2ip, glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1, [RH, Score=240, Expect=1e-64]} {Dmel: FBgn0025641, DAAM, Dishevelled Associated Activator of Morphogenesis, [RH, Score=167, Expect=2e-41]} {Celegans: WBGene00018976, daam-1, DAAM (Disheveled-Associated Activator of Morphogenesis) homolog, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_2533_0_1, dd_Smed_v6_2533_0_1, [RH, Score=138, Expect=1e-32]} {RNA1509_53930} {RNA1310_5747} {RNA815_10432} Mlig455_026827 {REF} {Length: 3037} {Pfam: PDZ domain [PF00595.26, score=102.7]; PDZ domain [PF17820.3, score=98.3]; PDZ domain [PF13180.8, score=71.4]; Cerebral cavernous malformation protein, harmonin-homology [PF16545.7, score=24.9]} {Human: ENSG00000215045, GRID2IP, Grid2 interacting protein, [Score=159, Expect=3e-39]} {Mouse: ENSMUSG00000010825, Grid2ip, glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1, [Score=101, Expect=2e-21]} {Dmel: FBgn0261859, CG42788, [RH, Score=55.8, Expect=2e-07]} {Smed: dd_Smed_v6_2888_0_1, dd_Smed_v6_2888_0_1, [Score=50.1, Expect=9e-07]} {RNA1509_53930} {RNA1310_4985} {RNA815_10432} Mlig455_030869 {REF} {Length: 5509} {Pfam: Formin Homology 2 Domain [PF02181.25, score=277.7]; PDZ domain [PF00595.26, score=100.5]; PDZ domain [PF17820.3, score=94.3]; PDZ domain [PF13180.8, score=68.9]; Cerebral cavernous malformation protein, harmonin-homology [PF16545.7, score=22.8]} {Human: ENSG00000215045, GRID2IP, Grid2 interacting protein, [RH, Score=245, Expect=5e-66]} {Mouse: ENSMUSG00000010825, Grid2ip, glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1, [RH, Score=241, Expect=3e-64]} {Dmel: FBgn0025641, DAAM, Dishevelled Associated Activator of Morphogenesis, [RH, Score=167, Expect=2e-41]} {Celegans: WBGene00018976, daam-1, DAAM (Disheveled-Associated Activator of Morphogenesis) homolog, [RH, Score=124, Expect=3e-28]} {Smed: dd_Smed_v6_2533_0_1, dd_Smed_v6_2533_0_1, [RH, Score=138, Expect=1e-32]} {RNA1509_53930} {RNA1310_5747} {RNA815_10432} |
59. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 0.953 | 0.953 | - | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
60. | MligTC455_31765 | 45 | 0.94 | Mlig455_061204 | Neo: - Age: logFC(26M/2M)=-0.372 |
LMNB1 | 0.952 | 0.952 | - | - | - | - | - | Mlig455_061204 {REF} {Length: 3048} {Pfam: Intermediate filament protein [PF00038.23, score=149.5]} {Human: ENSG00000113368, LMNB1, lamin B1, [Score=110, Expect=3e-25]; ENSG00000160789, LMNA, lamin A/C, [Score=105, Expect=4e-23]} {Mouse: ENSMUSG00000024590, Lmnb1, lamin B1, [Score=109, Expect=9e-25]; ENSMUSG00000028063, Lmna, lamin A, [Score=104, Expect=4e-23]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=123, Expect=1e-29]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=233, Expect=3e-69]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=276, Expect=8e-86]} {RNA1509_56508} {RNA1310_5840} {RNA815_9167} |
61. | MligTC455_33460 | 155 | 3.24 | Mlig455_043671, Mlig455_043782, Mlig455_052607 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.867/0.03359 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_043671 {REF} {Length: 2416} {Pfam: SAP domain [PF02037.29, score=40.8]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_043782 {REF} {Length: 514} {Pfam: SAP domain [PF02037.29, score=37.7]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_052607 {REF} {Length: 497} {Pfam: SAP domain [PF02037.29, score=40.8]; SAP domain-containing new25 [PF18953.2, score=19.6]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} |
|
62. | MligTC455_39762 | 11 | 0.22 | Mlig455_070144 | Neo: - Age: - |
WWP1 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_070144 {REF} {Length: 2640} {TRANSSPLICED} {Pfam: HECT-domain (ubiquitin-transferase) [PF00632.27, score=336.8]; WW domain [PF00397.28, score=156.1]; C2 domain [PF00168.32, score=30.1]} {Human: ENSG00000123124, WWP1, WW domain containing E3 ubiquitin protein ligase 1, [RH, Score=814, Expect=0.0]; ENSG00000198373, WWP2, WW domain containing E3 ubiquitin protein ligase 2, [RH, Score=808, Expect=0.0]; ENSG00000078747, ITCH, itchy E3 ubiquitin protein ligase, [RH, Score=789, Expect=0.0]} {Mouse: ENSMUSG00000041058, Wwp1, WW domain containing E3 ubiquitin protein ligase 1, [RH, Score=837, Expect=0.0]; ENSMUSG00000031930, Wwp2, WW domain containing E3 ubiquitin protein ligase 2, [RH, Score=808, Expect=0.0]} {Dmel: FBgn0003557, Su(dx), Suppressor of deltex, [RH, Score=800, Expect=0.0]} {Celegans: WBGene00007009, wwp-1, E3 ubiquitin-protein ligase, [RH, Score=779, Expect=0.0]} {Smed: dd_Smed_v6_1444_0_1, dd_Smed_v6_1444_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_7131} {RNA1310_8177, RNA1509_7131} {RNA1509_7131, RNA815_2686} |
63. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
64. | MligTC455_02414 | 26 | 0.54 | Mlig455_045881 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_045881 {REF} {Length: 1673} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=36.4]} {RNA1509_43636} {RNA1310_20957.1} {RNA815_41235} | |
65. | MligTC455_14086 | 13 | 0.27 | Mlig455_005016 | Neo: - Age: Down-Up-Down |
SEC14L4 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_005016 {REF} {Length: 1616} {Pfam: CRAL/TRIO domain [PF00650.22, score=73.6]} {Human: ENSG00000133488, SEC14L4, SEC14 like lipid binding 4, [Score=138, Expect=4e-37]; ENSG00000100003, SEC14L2, SEC14 like lipid binding 2, [Score=134, Expect=2e-35]} {Mouse: ENSMUSG00000054986, Sec14l3, SEC14-like lipid binding 3, [Score=140, Expect=9e-38]; ENSMUSG00000003585, Sec14l2, SEC14-like lipid binding 2, [Score=139, Expect=2e-37]} {Dmel: FBgn0035146, CG13893, [Score=89.7, Expect=1e-19]} {Celegans: WBGene00011962, T23G5.2, CRAL-TRIO domain-containing protein T23G5.2, [Score=98.6, Expect=2e-22]} {Smed: dd_Smed_v6_12821_0_1, dd_Smed_v6_12821_0_1, [Score=149, Expect=9e-42]} {RNA1509_52050} {RNA1310_31007} {RNA815_24143} |
66. | MligTC455_21579 | 61 | 1.28 | Mlig455_043460 | Neo: - Age: - |
0.951 | 0.951 | - | - | - | - | - | Mlig455_043460 {REF} {Length: 2967} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=46.8]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=80.5, Expect=2e-18]} {RNA1310_30353} {RNA815_17896} | |
67. | MligTC455_51159 | 49 | 1.03 | Mlig455_068260 | Neo: - Age: - |
SSPO | 0.951 | 0.951 | - | - | - | - | - | Mlig455_068260 {REF} {Length: 3064} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=45.9]; C8 domain [PF08742.13, score=40.0]; von Willebrand factor type D domain [PF00094.27, score=26.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=125, Expect=4e-29]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=115, Expect=6e-26]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=87.4, Expect=2e-17]} {Celegans: WBGene00003072, lrp-2, Low-density lipoprotein RecePtor related, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=141, Expect=8e-35]} {RNA1509_32065} {RNA1310_11674.1} {RNA815_35239} |